Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally Via Drinking Water in Rats

R Rygula,C Hiemke,N Abumaria,G Fluegge,E Ruether,U Havemann-Reinecke
DOI: https://doi.org/10.1055/s-2005-862689
2005-01-01
Pharmacopsychiatry
Abstract:Citalopram, a selective Serotonin Reuptake Inhibitor (SSRI), is used for treatment of depressive disorders. In man, citalopram is administered orally and therapeutic concentrations are established. However, little is known about the various clinical effects occurring in relation to the corresponding therapeutic concentrations. Therefore an animal model of depression was developed in rats by using psychosocial stress with therapeutic drug monitoring to further evaluate this question. The half-life of citalopram, however, is different in human and rodents. Rats metabolize the drug 5 to 10 times faster than humans. Therefore a citalopram monitoring study was done.
What problem does this paper attempt to address?